Free Trial

TransMedics Group (TMDX) Competitors

TransMedics Group logo
$128.91 +9.37 (+7.84%)
Closing price 04:00 PM Eastern
Extended Trading
$129.00 +0.09 (+0.07%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TMDX vs. SNN, SOLV, PEN, STVN, IRTC, BLCO, GKOS, SLNO, NVST, and LIVN

Should you be buying TransMedics Group stock or one of its competitors? The main competitors of TransMedics Group include Smith & Nephew SNATS (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), Glaukos (GKOS), Soleno Therapeutics (SLNO), Envista (NVST), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry.

TransMedics Group vs. Its Competitors

TransMedics Group (NASDAQ:TMDX) and Smith & Nephew SNATS (NYSE:SNN) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment and earnings.

TransMedics Group has a beta of 2.08, meaning that its share price is 108% more volatile than the S&P 500. Comparatively, Smith & Nephew SNATS has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500.

In the previous week, TransMedics Group had 7 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 11 mentions for TransMedics Group and 4 mentions for Smith & Nephew SNATS. Smith & Nephew SNATS's average media sentiment score of 1.44 beat TransMedics Group's score of 0.75 indicating that Smith & Nephew SNATS is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TransMedics Group
4 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Smith & Nephew SNATS
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

99.7% of TransMedics Group shares are held by institutional investors. Comparatively, 25.6% of Smith & Nephew SNATS shares are held by institutional investors. 7.0% of TransMedics Group shares are held by insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

TransMedics Group currently has a consensus price target of $130.73, suggesting a potential upside of 1.41%. Smith & Nephew SNATS has a consensus price target of $36.75, suggesting a potential upside of 0.56%. Given TransMedics Group's stronger consensus rating and higher probable upside, equities research analysts plainly believe TransMedics Group is more favorable than Smith & Nephew SNATS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TransMedics Group
0 Sell rating(s)
5 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.62
Smith & Nephew SNATS
0 Sell rating(s)
8 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.11

TransMedics Group has a net margin of 13.49% compared to Smith & Nephew SNATS's net margin of 0.00%. TransMedics Group's return on equity of 28.02% beat Smith & Nephew SNATS's return on equity.

Company Net Margins Return on Equity Return on Assets
TransMedics Group13.49% 28.02% 8.64%
Smith & Nephew SNATS N/A N/A N/A

Smith & Nephew SNATS has higher revenue and earnings than TransMedics Group. Smith & Nephew SNATS is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TransMedics Group$441.54M9.95$35.46M$1.9366.79
Smith & Nephew SNATS$5.81B2.68$412M$2.1616.92

Summary

TransMedics Group beats Smith & Nephew SNATS on 12 of the 16 factors compared between the two stocks.

Get TransMedics Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMDX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TMDX vs. The Competition

MetricTransMedics GroupMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$4.08B$7.57B$6.19B$10.60B
Dividend YieldN/A1.13%5.72%4.86%
P/E Ratio66.7927.3229.6428.46
Price / Sales9.9527.88577.46128.87
Price / Cash72.6522.5936.5560.64
Price / Book18.935.2512.076.53
Net Income$35.46M$178.09M$3.32B$276.75M
7 Day Performance11.44%-0.42%-0.16%0.20%
1 Month Performance6.95%1.15%5.76%1.67%
1 Year Performance8.64%2.87%65.71%32.73%

TransMedics Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TMDX
TransMedics Group
2.2614 of 5 stars
$128.91
+7.8%
$130.73
+1.4%
-2.8%$4.08B$441.54M66.79210News Coverage
Upcoming Earnings
Analyst Upgrade
Gap Up
SNN
Smith & Nephew SNATS
3.266 of 5 stars
$36.38
+0.1%
$36.75
+1.0%
+26.1%$15.55B$5.81B16.8617,349Analyst Forecast
SOLV
Solventum
2.2764 of 5 stars
$73.01
+1.2%
$84.89
+16.3%
+0.2%$12.65B$8.25B33.7922,000
PEN
Penumbra
4.7595 of 5 stars
$245.13
-1.6%
$302.81
+23.5%
+22.5%$9.57B$1.19B65.274,500
STVN
Stevanato Group
1.2576 of 5 stars
€25.18
+3.0%
N/A+44.0%€7.60B€1.19B46.465,521Positive News
IRTC
iRhythm Technologies
1.4604 of 5 stars
$178.72
-1.7%
$184.85
+3.4%
+134.0%$5.75B$591.84M-61.092,000Upcoming Earnings
BLCO
Bausch + Lomb
1.4544 of 5 stars
$15.39
+2.6%
$15.70
+2.0%
-22.6%$5.44B$4.79B-19.7013,500News Coverage
Upcoming Earnings
GKOS
Glaukos
4.5262 of 5 stars
$78.63
-9.8%
$116.92
+48.7%
-41.9%$4.56B$383.48M-48.21780Upcoming Earnings
Analyst Forecast
SLNO
Soleno Therapeutics
4.2876 of 5 stars
$65.26
-0.3%
$115.92
+77.6%
+24.7%$3.47BN/A-15.7930
NVST
Envista
3.8888 of 5 stars
$20.15
+0.9%
$21.08
+4.6%
+6.4%$3.35B$2.51B62.9612,300News Coverage
Upcoming Earnings
LIVN
LivaNova
2.9038 of 5 stars
$53.37
-0.7%
$59.71
+11.9%
+2.9%$2.92B$1.25B-13.742,900News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:TMDX) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners